Skip to main content
Top
Published in: Virology Journal 1/2022

Open Access 01-12-2022 | Hepatitis B | Research

Sparse logistic regression revealed the associations between HBV PreS quasispecies and hepatocellular carcinoma

Authors: Jian-an Jia, Shuqin Zhang, Xin Bai, Meng Fang, Shipeng Chen, Xiaotao Liang, Shanfeng Zhu, Danny Ka-Ho Wong, Anye Zhang, Jianfeng Feng, Fengzhu Sun, Chunfang Gao

Published in: Virology Journal | Issue 1/2022

Login to get access

Abstract

Background

Chronic infection with hepatitis B virus (HBV) has been proved highly associated with the development of hepatocellular carcinoma (HCC).

Aims

The purpose of the study is to investigate the association between HBV preS region quasispecies and HCC development, as well as to develop HCC diagnosis model using HBV preS region quasispecies.

Methods

A total of 104 chronic hepatitis B (CHB) patients and 117 HBV-related HCC patients were enrolled. HBV preS region was sequenced using next generation sequencing (NGS) and the nucleotide entropy was calculated for quasispecies evaluation. Sparse logistic regression (SLR) was used to predict HCC development and prediction performances were evaluated using receiver operating characteristic curves.

Results

Entropy of HBV preS1, preS2 regions and several nucleotide points showed significant divergence between CHB and HCC patients. Using SLR, the classification of HCC/CHB groups achieved a mean area under the receiver operating characteristic curve (AUC) of 0.883 in the training data and 0.795 in the test data. The prediction model was also validated by a completely independent dataset from Hong Kong. The 10 selected nucleotide positions showed significantly different entropy between CHB and HCC patients. The HBV quasispecies also classified three clinical parameters, including HBeAg, HBVDNA, and Alkaline phosphatase (ALP) with the AUC value greater than 0.6 in the test data.

Conclusions

Using NGS and SLR, the association between HBV preS region nucleotide entropy and HCC development was validated in our study and this could promote the understanding of HCC progression mechanism.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.PubMedCrossRef
3.
go back to reference Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.PubMedPubMedCentralCrossRef Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.PubMedPubMedCentralCrossRef
5.
go back to reference Zhu Y, Jin Y, Guo X, Bai X, Chen T, Wang J, Qian G, Groopman JD, Gu J, Li J, Tu H. Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2623–30.PubMedCrossRef Zhu Y, Jin Y, Guo X, Bai X, Chen T, Wang J, Qian G, Groopman JD, Gu J, Li J, Tu H. Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2623–30.PubMedCrossRef
6.
go back to reference Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 2006;130(4):1153–68.PubMedCrossRef Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 2006;130(4):1153–68.PubMedCrossRef
7.
go back to reference Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, Fang KX, Yang JY, Huang J, Wang XY, Harrison TJ. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol. 2008;89(Pt 11):2882–90.PubMedPubMedCentralCrossRef Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, Fang KX, Yang JY, Huang J, Wang XY, Harrison TJ. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol. 2008;89(Pt 11):2882–90.PubMedPubMedCentralCrossRef
8.
go back to reference Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, Zhu ZD, Zhou B, Liu XY, Liu RF, Fei QL, Chen H, Cai B, Zhou B, Xiao HS, Qin LX, Han ZG. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet. 2012;44(10):1117–21.PubMedCrossRef Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, Zhu ZD, Zhou B, Liu XY, Liu RF, Fei QL, Chen H, Cai B, Zhou B, Xiao HS, Qin LX, Han ZG. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet. 2012;44(10):1117–21.PubMedCrossRef
9.
go back to reference Li F, Zhang D, Li Y, Jiang D, Luo S, Du N, Chen W, Deng L, Zeng C. Whole genome characterization of hepatitis B virus quasispecies with massively parallel pyrosequencing. Clin Microbiol Infect. 2015;21(3):280–7.PubMedCrossRef Li F, Zhang D, Li Y, Jiang D, Luo S, Du N, Chen W, Deng L, Zeng C. Whole genome characterization of hepatitis B virus quasispecies with massively parallel pyrosequencing. Clin Microbiol Infect. 2015;21(3):280–7.PubMedCrossRef
10.
go back to reference Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009;101(15):1066–82.PubMedPubMedCentralCrossRef Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009;101(15):1066–82.PubMedPubMedCentralCrossRef
11.
go back to reference Shen FC, Su IJ, Wu HC, Hsieh YH, Yao WJ, Young KC, Chang TC, Hsieh HC, Tsai HN, Huang W. A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers. J Biomed Sci. 2009;16:84.PubMedPubMedCentralCrossRef Shen FC, Su IJ, Wu HC, Hsieh YH, Yao WJ, Young KC, Chang TC, Hsieh HC, Tsai HN, Huang W. A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers. J Biomed Sci. 2009;16:84.PubMedPubMedCentralCrossRef
12.
go back to reference Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, Mulawadi FH, Wong KF, Liu AM, Poon RT, Fan ST, Chan KL, Gong Z, Hu Y, Lin Z, Wang G, Zhang Q, Barber TD, Chou WC, Aggarwal A, Hao K, Zhou W, Zhang C, Hardwick J, Buser C, Xu J, Kan Z, Dai H, Mao M, Reinhard C, Wang J, Luk JM. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012;44(7):765–9.PubMedCrossRef Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, Mulawadi FH, Wong KF, Liu AM, Poon RT, Fan ST, Chan KL, Gong Z, Hu Y, Lin Z, Wang G, Zhang Q, Barber TD, Chou WC, Aggarwal A, Hao K, Zhou W, Zhang C, Hardwick J, Buser C, Xu J, Kan Z, Dai H, Mao M, Reinhard C, Wang J, Luk JM. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012;44(7):765–9.PubMedCrossRef
13.
go back to reference Yeh CT, So M, Ng J, Yang HW, Chang ML, Lai MW, Chen TC, Lin CY, Yeh TS, Lee WC. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology. 2010;52(6):1922–33.PubMedCrossRef Yeh CT, So M, Ng J, Yang HW, Chang ML, Lai MW, Chen TC, Lin CY, Yeh TS, Lee WC. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology. 2010;52(6):1922–33.PubMedCrossRef
14.
go back to reference Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W, Wang H, Cao G. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol. 2010;45(10):1063–71.PubMedCrossRef Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W, Wang H, Cao G. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol. 2010;45(10):1063–71.PubMedCrossRef
15.
go back to reference Zhang D, Dong P, Zhang K, Deng L, Bach C, Chen W, Li F, Protzer U, Ding H, Zeng C. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment. Bmc Microbiol. 2012;12:307.PubMedPubMedCentralCrossRef Zhang D, Dong P, Zhang K, Deng L, Bach C, Chen W, Li F, Protzer U, Ding H, Zeng C. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment. Bmc Microbiol. 2012;12:307.PubMedPubMedCentralCrossRef
16.
go back to reference Zhang AY, Lai CL, Huang FY, Seto WK, Fung J, Wong DK, Yuen MF. Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma. J Gastroenterol. 2017;52(9):1064–74.PubMedCrossRef Zhang AY, Lai CL, Huang FY, Seto WK, Fung J, Wong DK, Yuen MF. Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma. J Gastroenterol. 2017;52(9):1064–74.PubMedCrossRef
17.
go back to reference Pollicino T, Cacciola I, Saffioti F, Raimondo G. Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications. J Hepatol. 2014;61(2):408–17.PubMedCrossRef Pollicino T, Cacciola I, Saffioti F, Raimondo G. Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications. J Hepatol. 2014;61(2):408–17.PubMedCrossRef
18.
go back to reference Chevaliez S, Pawlotsky JM. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings. J Hepatol. 2018;69(4):916–26.PubMedCrossRef Chevaliez S, Pawlotsky JM. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings. J Hepatol. 2018;69(4):916–26.PubMedCrossRef
19.
go back to reference Ko SY, Oh HB, Park CW, Lee HC, Lee JE. Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing. Clin Microbiol Infect. 2012;18(10):E404–11.PubMedCrossRef Ko SY, Oh HB, Park CW, Lee HC, Lee JE. Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing. Clin Microbiol Infect. 2012;18(10):E404–11.PubMedCrossRef
20.
go back to reference Rodriguez C, Chevaliez S, Bensadoun P, Pawlotsky JM. Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing. Hepatology. 2013;58(3):890–901.PubMedCrossRef Rodriguez C, Chevaliez S, Bensadoun P, Pawlotsky JM. Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing. Hepatology. 2013;58(3):890–901.PubMedCrossRef
21.
go back to reference Gong L, Han Y, Chen L, Liu F, Hao P, Sheng J, Li XH, Yu DM, Gong QM, Tian F, Guo XK, Zhang XX. Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity. J Clin Microbiol. 2013;51(12):4087–94.PubMedPubMedCentralCrossRef Gong L, Han Y, Chen L, Liu F, Hao P, Sheng J, Li XH, Yu DM, Gong QM, Tian F, Guo XK, Zhang XX. Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity. J Clin Microbiol. 2013;51(12):4087–94.PubMedPubMedCentralCrossRef
22.
go back to reference Han Y, Gong L, Sheng J, Liu F, Li XH, Chen L, Yu DM, Gong QM, Hao P, Zhang XX. Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation sequencing. Clin Microbiol Infect. 2015;21(8):791–7.CrossRef Han Y, Gong L, Sheng J, Liu F, Li XH, Chen L, Yu DM, Gong QM, Hao P, Zhang XX. Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation sequencing. Clin Microbiol Infect. 2015;21(8):791–7.CrossRef
23.
go back to reference Liu WC, Wu IC, Lee YC, Lin CP, Cheng JH, Lin YJ, Yen CJ, Cheng PN, Li PF, Cheng YT, Cheng PW, Sun KT, Yan SL, Lin JJ, Yang JC, Chang KC, Ho CH, Tseng VS, Chang BC, Wu JC, Chang TT. Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus. J Pathol. 2017;243(2):176–92.PubMedCrossRef Liu WC, Wu IC, Lee YC, Lin CP, Cheng JH, Lin YJ, Yen CJ, Cheng PN, Li PF, Cheng YT, Cheng PW, Sun KT, Yan SL, Lin JJ, Yang JC, Chang KC, Ho CH, Tseng VS, Chang BC, Wu JC, Chang TT. Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus. J Pathol. 2017;243(2):176–92.PubMedCrossRef
24.
go back to reference Bai X, Jia J, Fang M, Chen S, Liang X, Zhu S, Zhang S, Feng J, Sun F, Gao C. Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC. Plos Genet. 2018;14(2):e1007206.PubMedPubMedCentralCrossRef Bai X, Jia J, Fang M, Chen S, Liang X, Zhu S, Zhang S, Feng J, Sun F, Gao C. Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC. Plos Genet. 2018;14(2):e1007206.PubMedPubMedCentralCrossRef
25.
go back to reference Jia JA, Liang X, Chen S, Wang H, Li H, Fang M, Bai X, Wang Z, Wang M, Zhu S, Sun F, Gao C. Next-generation sequencing revealed divergence in deletions of the preS region in the HBV genome between different HBV-related liver diseases. J Gen Virol. 2017;98(11):2748–58.PubMedCrossRef Jia JA, Liang X, Chen S, Wang H, Li H, Fang M, Bai X, Wang Z, Wang M, Zhu S, Sun F, Gao C. Next-generation sequencing revealed divergence in deletions of the preS region in the HBV genome between different HBV-related liver diseases. J Gen Virol. 2017;98(11):2748–58.PubMedCrossRef
26.
go back to reference Teng CF, Li TC, Huang HY, Lin JH, Chen WS, Shyu WC, Wu HC, Peng CY, Su IJ, Jeng LB. Next-generation sequencing-based quantitative detection of hepatitis B virus Pre-S mutants in plasma predicts hepatocellular carcinoma recurrence. Viruses. 2020;12(8):796.PubMedCentralCrossRef Teng CF, Li TC, Huang HY, Lin JH, Chen WS, Shyu WC, Wu HC, Peng CY, Su IJ, Jeng LB. Next-generation sequencing-based quantitative detection of hepatitis B virus Pre-S mutants in plasma predicts hepatocellular carcinoma recurrence. Viruses. 2020;12(8):796.PubMedCentralCrossRef
27.
go back to reference Teng CF, Huang HY, Li TC, Shyu WC, Wu HC, Lin CY, Su IJ, Jeng LB. A next-generation sequencing-based platform for quantitative detection of hepatitis B virus Pre-S mutants in plasma of hepatocellular carcinoma patients. Sci Rep. 2018;8(1):14816.PubMedPubMedCentralCrossRef Teng CF, Huang HY, Li TC, Shyu WC, Wu HC, Lin CY, Su IJ, Jeng LB. A next-generation sequencing-based platform for quantitative detection of hepatitis B virus Pre-S mutants in plasma of hepatocellular carcinoma patients. Sci Rep. 2018;8(1):14816.PubMedPubMedCentralCrossRef
28.
go back to reference Zhang AY, Lai CL, Huang FY, Seto WK, Fung J, Wong DK, Yuen MF. Evolutionary changes of hepatitis B virus Pre-S mutations prior to development of hepatocellular carcinoma. PLoS ONE. 2015;10(9):e139478.CrossRef Zhang AY, Lai CL, Huang FY, Seto WK, Fung J, Wong DK, Yuen MF. Evolutionary changes of hepatitis B virus Pre-S mutations prior to development of hepatocellular carcinoma. PLoS ONE. 2015;10(9):e139478.CrossRef
29.
go back to reference Zhang A, Lai C, Poon RT, Huang F, Seto W, Fung J, Wong DK, Yuen M. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma. J Gastroen Hepatol. 2016;31(9):1638–45.CrossRef Zhang A, Lai C, Poon RT, Huang F, Seto W, Fung J, Wong DK, Yuen M. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma. J Gastroen Hepatol. 2016;31(9):1638–45.CrossRef
30.
go back to reference Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br J Surg. 2015;102(3):148–58.PubMedCrossRef Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br J Surg. 2015;102(3):148–58.PubMedCrossRef
32.
go back to reference Myers R, Clark C, Khan A, Kellam P, Tedder R. Genotyping Hepatitis B virus from whole- and sub-genomic fragments using position-specific scoring matrices in HBV STAR. J Gen Virol. 2006;87(Pt 6):1459–64.PubMedCrossRef Myers R, Clark C, Khan A, Kellam P, Tedder R. Genotyping Hepatitis B virus from whole- and sub-genomic fragments using position-specific scoring matrices in HBV STAR. J Gen Virol. 2006;87(Pt 6):1459–64.PubMedCrossRef
33.
go back to reference Tibshirani R, Bien J, Friedman J, Hastie T, Simon N, Taylor J, Tibshirani RJ. Strong rules for discarding predictors in lasso-type problems. J R Stat Soc Ser B Stat Methodol. 2012;74(2):245–66.CrossRef Tibshirani R, Bien J, Friedman J, Hastie T, Simon N, Taylor J, Tibshirani RJ. Strong rules for discarding predictors in lasso-type problems. J R Stat Soc Ser B Stat Methodol. 2012;74(2):245–66.CrossRef
34.
go back to reference Chun H, Kele S. Sparse partial least squares regression for simultaneous dimension reduction and variable selection. J R Stat Soc Ser B Stat Methodol. 2010;72(1):3–25.CrossRef Chun H, Kele S. Sparse partial least squares regression for simultaneous dimension reduction and variable selection. J R Stat Soc Ser B Stat Methodol. 2010;72(1):3–25.CrossRef
35.
go back to reference Pirooznia M, Deng Y. SVM Classifier - a comprehensive java interface for support vector machine classification of microarray data. BMC Bioinform. 2006;7(Suppl 4):S25.CrossRef Pirooznia M, Deng Y. SVM Classifier - a comprehensive java interface for support vector machine classification of microarray data. BMC Bioinform. 2006;7(Suppl 4):S25.CrossRef
37.
go back to reference Huang CYJ. Semismooth newton coordinate descent algorithm for elastic-net penalized huber loss regression and quantile regression. J Comput Graph Stat. 2017;26(3):547–57.CrossRef Huang CYJ. Semismooth newton coordinate descent algorithm for elastic-net penalized huber loss regression and quantile regression. J Comput Graph Stat. 2017;26(3):547–57.CrossRef
38.
go back to reference Platt JC. Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods. Cambridge: MIT Press; 1999. p. 61–74. Platt JC. Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods. Cambridge: MIT Press; 1999. p. 61–74.
39.
go back to reference Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KGM. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol. 2003;56(5):441–7.PubMedCrossRef Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KGM. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol. 2003;56(5):441–7.PubMedCrossRef
40.
go back to reference Dong X, He H, Zhang W, Yu D, Wang X, Chen Y. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection. Diagn Pathol. 2015;10:133.PubMedPubMedCentralCrossRef Dong X, He H, Zhang W, Yu D, Wang X, Chen Y. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection. Diagn Pathol. 2015;10:133.PubMedPubMedCentralCrossRef
41.
go back to reference Chen S, Zhang Z, Wang Y, Fang M, Zhou J, Li Y, Dai E, Feng Z, Wang H, Yang Z, Li Y, Huang X, Jia JA, Li S, Huang C, Tong L, Xiao X, He Y, Duan Y, Zhu S, Gao C. Using quasispecies patterns of hepatitis B virus to predict hepatocellular carcinoma with deep sequencing and machine learning. J Infect Dis. 2021;223(11):1887–96.PubMedCrossRef Chen S, Zhang Z, Wang Y, Fang M, Zhou J, Li Y, Dai E, Feng Z, Wang H, Yang Z, Li Y, Huang X, Jia JA, Li S, Huang C, Tong L, Xiao X, He Y, Duan Y, Zhu S, Gao C. Using quasispecies patterns of hepatitis B virus to predict hepatocellular carcinoma with deep sequencing and machine learning. J Infect Dis. 2021;223(11):1887–96.PubMedCrossRef
42.
go back to reference Dash S, Panda SK, Nayak NC. Polymerized albumin binding to serum in various liver diseases: its significance and relation to hepatitis B virus infection. J Gastroenterol Hepatol. 1990;5(1):16–24.PubMedCrossRef Dash S, Panda SK, Nayak NC. Polymerized albumin binding to serum in various liver diseases: its significance and relation to hepatitis B virus infection. J Gastroenterol Hepatol. 1990;5(1):16–24.PubMedCrossRef
43.
go back to reference Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao J, Han X, Zhang H, Cao G. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. J Virol. 2013;87(22):12176–86.PubMedPubMedCentralCrossRef Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao J, Han X, Zhang H, Cao G. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. J Virol. 2013;87(22):12176–86.PubMedPubMedCentralCrossRef
44.
go back to reference Livezey KW, Negorev D, Simon D. Hepatitis B virus-transfected Hep G2 cells demonstrate genetic alterations and de novo viral integration in cells replicating HBV. Mutat Res. 2000;452(2):163–78.PubMedCrossRef Livezey KW, Negorev D, Simon D. Hepatitis B virus-transfected Hep G2 cells demonstrate genetic alterations and de novo viral integration in cells replicating HBV. Mutat Res. 2000;452(2):163–78.PubMedCrossRef
45.
go back to reference Jiang SZ, Gao ZY, Li T, Li YJ, Chen XM, Wang L, Lu FM, Zhuang H. T3098C and T53C mutations of HBV genotype C is associated with HBV infection progress. Biomed Environ Sci. 2009;22(6):511–7.PubMedCrossRef Jiang SZ, Gao ZY, Li T, Li YJ, Chen XM, Wang L, Lu FM, Zhuang H. T3098C and T53C mutations of HBV genotype C is associated with HBV infection progress. Biomed Environ Sci. 2009;22(6):511–7.PubMedCrossRef
46.
go back to reference Jose-Abrego A, Roman S, Rebello PJ, de Castro V, Panduro A. Hepatitis B virus (HBV) genotype mixtures, viral load, and liver damage in HBV patients co-infected with human immunodeficiency virus. Front Microbiol. 2021;12:640889.PubMedPubMedCentralCrossRef Jose-Abrego A, Roman S, Rebello PJ, de Castro V, Panduro A. Hepatitis B virus (HBV) genotype mixtures, viral load, and liver damage in HBV patients co-infected with human immunodeficiency virus. Front Microbiol. 2021;12:640889.PubMedPubMedCentralCrossRef
47.
go back to reference Hannoun C, Krogsgaard K, Horal P, Lindh M. Genotype mixtures of hepatitis B virus in patients treated with interferon. J Infect Dis. 2002;186(6):752–9.PubMedCrossRef Hannoun C, Krogsgaard K, Horal P, Lindh M. Genotype mixtures of hepatitis B virus in patients treated with interferon. J Infect Dis. 2002;186(6):752–9.PubMedCrossRef
48.
go back to reference Xie Y, Hepatitis B. Virus-associated hepatocellular carcinoma. Adv Exp Med Biol. 2017;1018:11–21.PubMedCrossRef Xie Y, Hepatitis B. Virus-associated hepatocellular carcinoma. Adv Exp Med Biol. 2017;1018:11–21.PubMedCrossRef
49.
go back to reference Wong DK, Kopaniszen M, Omagari K, Tanaka Y, Fong DY, Seto WK, Fung J, Huang FY, Zhang AY, Hung IF, Lai CL, Yuen MF. Effect of hepatitis B virus reverse transcriptase variations on entecavir treatment response. J Infect Dis. 2014;210(5):701–7.PubMedCrossRef Wong DK, Kopaniszen M, Omagari K, Tanaka Y, Fong DY, Seto WK, Fung J, Huang FY, Zhang AY, Hung IF, Lai CL, Yuen MF. Effect of hepatitis B virus reverse transcriptase variations on entecavir treatment response. J Infect Dis. 2014;210(5):701–7.PubMedCrossRef
50.
go back to reference Liang Y, Liu C, Luan XZ, Leung KS, Chan TM, Xu ZB, Zhang H. Sparse logistic regression with a L1/2 penalty for gene selection in cancer classification. BMC Bioinform. 2013;14:198.CrossRef Liang Y, Liu C, Luan XZ, Leung KS, Chan TM, Xu ZB, Zhang H. Sparse logistic regression with a L1/2 penalty for gene selection in cancer classification. BMC Bioinform. 2013;14:198.CrossRef
51.
go back to reference Liu Z, Jiang F, Tian G, Wang S, Sato F, Meltzer SJ, Tan M. Sparse logistic regression with Lp penalty for biomarker identification. Stat Appl Genet Mol Biol. 2007;6:e6.CrossRef Liu Z, Jiang F, Tian G, Wang S, Sato F, Meltzer SJ, Tan M. Sparse logistic regression with Lp penalty for biomarker identification. Stat Appl Genet Mol Biol. 2007;6:e6.CrossRef
52.
go back to reference Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE Jr, Moons KG, Collins GS. Minimum sample size for developing a multivariable prediction model: part II—binary and time-to-event outcomes. Stat Med. 2019;38(7):1276–96.PubMedCrossRef Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE Jr, Moons KG, Collins GS. Minimum sample size for developing a multivariable prediction model: part II—binary and time-to-event outcomes. Stat Med. 2019;38(7):1276–96.PubMedCrossRef
53.
go back to reference Riley RD, Debray TPA, Collins GS, Archer L, Ensor J, Smeden M, Snell KIE. Minimum sample size for external validation of a clinical prediction model with a binary outcome. Stat Med. 2021;40(19):4230–51.PubMedCrossRef Riley RD, Debray TPA, Collins GS, Archer L, Ensor J, Smeden M, Snell KIE. Minimum sample size for external validation of a clinical prediction model with a binary outcome. Stat Med. 2021;40(19):4230–51.PubMedCrossRef
Metadata
Title
Sparse logistic regression revealed the associations between HBV PreS quasispecies and hepatocellular carcinoma
Authors
Jian-an Jia
Shuqin Zhang
Xin Bai
Meng Fang
Shipeng Chen
Xiaotao Liang
Shanfeng Zhu
Danny Ka-Ho Wong
Anye Zhang
Jianfeng Feng
Fengzhu Sun
Chunfang Gao
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2022
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-022-01836-9

Other articles of this Issue 1/2022

Virology Journal 1/2022 Go to the issue